Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
33
IRTC Quote, Financials, Valuation and Earnings
Last price:
$176.30
Seasonality move
:
13.22%
Day range:
$176.89 - $180.40
52-week range:
$86.19 - $212.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.07x
P/B ratio:
47.17x
Volume:
537K
Avg. volume:
508.4K
1-year change:
101.27%
Market cap:
$5.7B
Revenue:
$591.8M
EPS (TTM):
-$1.62
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IRTC
iRhythm Technologies, Inc.
|
$184.7M | -$0.28 | 21.67% | -80.89% | $218.60 |
|
BAX
Baxter International, Inc.
|
$2.9B | $0.60 | 2.57% | 118.69% | $23.67 |
|
IART
Integra LifeSciences Holdings Corp.
|
$414.3M | $0.43 | -2.94% | 217.65% | $15.50 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.4B | $1.99 | 12.86% | 19.35% | $599.60 |
|
QDEL
QuidelOrtho Corp.
|
$663.5M | $0.47 | -1.13% | 480.41% | $37.67 |
|
TNDM
Tandem Diabetes Care, Inc.
|
$235.8M | -$0.34 | -2.02% | -4.07% | $24.81 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IRTC
iRhythm Technologies, Inc.
|
$178.45 | $218.60 | $5.7B | -- | $0.00 | 0% | 8.07x |
|
BAX
Baxter International, Inc.
|
$18.94 | $23.67 | $9.7B | 167.20x | $0.01 | 2.75% | 0.88x |
|
IART
Integra LifeSciences Holdings Corp.
|
$12.59 | $15.50 | $980.7M | 70.14x | $0.00 | 0% | 0.59x |
|
ISRG
Intuitive Surgical, Inc.
|
$577.34 | $599.60 | $204.7B | 76.42x | $0.00 | 0% | 21.84x |
|
QDEL
QuidelOrtho Corp.
|
$28.59 | $37.67 | $1.9B | -- | $0.00 | 0% | 0.71x |
|
TNDM
Tandem Diabetes Care, Inc.
|
$22.62 | $24.81 | $1.5B | -- | $0.00 | 0% | 1.50x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IRTC
iRhythm Technologies, Inc.
|
85.74% | 2.140 | 13.23% | 4.47x |
|
BAX
Baxter International, Inc.
|
57.29% | 0.027 | 83.18% | 0.96x |
|
IART
Integra LifeSciences Holdings Corp.
|
65.91% | 0.130 | 179.84% | 1.47x |
|
ISRG
Intuitive Surgical, Inc.
|
-- | 1.065 | -- | 3.42x |
|
QDEL
QuidelOrtho Corp.
|
58.27% | 1.095 | 142.21% | 0.82x |
|
TNDM
Tandem Diabetes Care, Inc.
|
77.16% | 1.243 | 54.61% | 1.79x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IRTC
iRhythm Technologies, Inc.
|
$137.1M | -$4M | -6.2% | -54.18% | -2.08% | $20.1M |
|
BAX
Baxter International, Inc.
|
$938M | $194M | -1.9% | -4.83% | 6.84% | $126M |
|
IART
Integra LifeSciences Holdings Corp.
|
$226.1M | $25.9M | -14.85% | -37.15% | 6.43% | $25.8M |
|
ISRG
Intuitive Surgical, Inc.
|
$1.7B | $759.7M | 16.35% | 16.38% | 30.33% | $735.6M |
|
QDEL
QuidelOrtho Corp.
|
$288.5M | $45.8M | -20.79% | -41.24% | 6.54% | -$94.7M |
|
TNDM
Tandem Diabetes Care, Inc.
|
$134.3M | -$20.1M | -31.16% | -110.24% | -8.05% | $4.2M |
iRhythm Technologies, Inc. vs. Competitors
-
Which has Higher Returns IRTC or BAX?
Baxter International, Inc. has a net margin of -2.7% compared to iRhythm Technologies, Inc.'s net margin of -1.8%. iRhythm Technologies, Inc.'s return on equity of -54.18% beat Baxter International, Inc.'s return on equity of -4.83%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M BAXBaxter International, Inc.33.09% $0.02 $16.9B -
What do Analysts Say About IRTC or BAX?
iRhythm Technologies, Inc. has a consensus price target of $218.60, signalling upside risk potential of 22.5%. On the other hand Baxter International, Inc. has an analysts' consensus of $23.67 which suggests that it could grow by 24.69%. Given that Baxter International, Inc. has higher upside potential than iRhythm Technologies, Inc., analysts believe Baxter International, Inc. is more attractive than iRhythm Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Technologies, Inc.11 2 0 BAXBaxter International, Inc.2 13 1 -
Is IRTC or BAX More Risky?
iRhythm Technologies, Inc. has a beta of 1.099, which suggesting that the stock is 9.93% more volatile than S&P 500. In comparison Baxter International, Inc. has a beta of 0.612, suggesting its less volatile than the S&P 500 by 38.771%.
-
Which is a Better Dividend Stock IRTC or BAX?
iRhythm Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Baxter International, Inc. offers a yield of 2.75% to investors and pays a quarterly dividend of $0.01 per share. iRhythm Technologies, Inc. pays -- of its earnings as a dividend. Baxter International, Inc. pays out 180.98% of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or BAX?
iRhythm Technologies, Inc. quarterly revenues are $192.9M, which are smaller than Baxter International, Inc. quarterly revenues of $2.8B. iRhythm Technologies, Inc.'s net income of -$5.2M is higher than Baxter International, Inc.'s net income of -$51M. Notably, iRhythm Technologies, Inc.'s price-to-earnings ratio is -- while Baxter International, Inc.'s PE ratio is 167.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Technologies, Inc. is 8.07x versus 0.88x for Baxter International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Technologies, Inc.8.07x -- $192.9M -$5.2M BAXBaxter International, Inc.0.88x 167.20x $2.8B -$51M
-
Which has Higher Returns IRTC or IART?
Integra LifeSciences Holdings Corp. has a net margin of -2.7% compared to iRhythm Technologies, Inc.'s net margin of -1.34%. iRhythm Technologies, Inc.'s return on equity of -54.18% beat Integra LifeSciences Holdings Corp.'s return on equity of -37.15%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M IARTIntegra LifeSciences Holdings Corp.56.24% -$0.07 $3B -
What do Analysts Say About IRTC or IART?
iRhythm Technologies, Inc. has a consensus price target of $218.60, signalling upside risk potential of 22.5%. On the other hand Integra LifeSciences Holdings Corp. has an analysts' consensus of $15.50 which suggests that it could grow by 23.11%. Given that Integra LifeSciences Holdings Corp. has higher upside potential than iRhythm Technologies, Inc., analysts believe Integra LifeSciences Holdings Corp. is more attractive than iRhythm Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Technologies, Inc.11 2 0 IARTIntegra LifeSciences Holdings Corp.2 4 2 -
Is IRTC or IART More Risky?
iRhythm Technologies, Inc. has a beta of 1.099, which suggesting that the stock is 9.93% more volatile than S&P 500. In comparison Integra LifeSciences Holdings Corp. has a beta of 1.064, suggesting its more volatile than the S&P 500 by 6.408%.
-
Which is a Better Dividend Stock IRTC or IART?
iRhythm Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integra LifeSciences Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iRhythm Technologies, Inc. pays -- of its earnings as a dividend. Integra LifeSciences Holdings Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or IART?
iRhythm Technologies, Inc. quarterly revenues are $192.9M, which are smaller than Integra LifeSciences Holdings Corp. quarterly revenues of $402.1M. iRhythm Technologies, Inc.'s net income of -$5.2M is higher than Integra LifeSciences Holdings Corp.'s net income of -$5.4M. Notably, iRhythm Technologies, Inc.'s price-to-earnings ratio is -- while Integra LifeSciences Holdings Corp.'s PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Technologies, Inc. is 8.07x versus 0.59x for Integra LifeSciences Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Technologies, Inc.8.07x -- $192.9M -$5.2M IARTIntegra LifeSciences Holdings Corp.0.59x 70.14x $402.1M -$5.4M
-
Which has Higher Returns IRTC or ISRG?
Intuitive Surgical, Inc. has a net margin of -2.7% compared to iRhythm Technologies, Inc.'s net margin of 28.31%. iRhythm Technologies, Inc.'s return on equity of -54.18% beat Intuitive Surgical, Inc.'s return on equity of 16.38%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M ISRGIntuitive Surgical, Inc.66.36% $1.95 $17B -
What do Analysts Say About IRTC or ISRG?
iRhythm Technologies, Inc. has a consensus price target of $218.60, signalling upside risk potential of 22.5%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $599.60 which suggests that it could grow by 3.86%. Given that iRhythm Technologies, Inc. has higher upside potential than Intuitive Surgical, Inc., analysts believe iRhythm Technologies, Inc. is more attractive than Intuitive Surgical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Technologies, Inc.11 2 0 ISRGIntuitive Surgical, Inc.14 11 1 -
Is IRTC or ISRG More Risky?
iRhythm Technologies, Inc. has a beta of 1.099, which suggesting that the stock is 9.93% more volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.682, suggesting its more volatile than the S&P 500 by 68.249%.
-
Which is a Better Dividend Stock IRTC or ISRG?
iRhythm Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iRhythm Technologies, Inc. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or ISRG?
iRhythm Technologies, Inc. quarterly revenues are $192.9M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.5B. iRhythm Technologies, Inc.'s net income of -$5.2M is lower than Intuitive Surgical, Inc.'s net income of $709.2M. Notably, iRhythm Technologies, Inc.'s price-to-earnings ratio is -- while Intuitive Surgical, Inc.'s PE ratio is 76.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Technologies, Inc. is 8.07x versus 21.84x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Technologies, Inc.8.07x -- $192.9M -$5.2M ISRGIntuitive Surgical, Inc.21.84x 76.42x $2.5B $709.2M
-
Which has Higher Returns IRTC or QDEL?
QuidelOrtho Corp. has a net margin of -2.7% compared to iRhythm Technologies, Inc.'s net margin of -104.64%. iRhythm Technologies, Inc.'s return on equity of -54.18% beat QuidelOrtho Corp.'s return on equity of -41.24%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M QDELQuidelOrtho Corp.41.19% -$10.78 $4.9B -
What do Analysts Say About IRTC or QDEL?
iRhythm Technologies, Inc. has a consensus price target of $218.60, signalling upside risk potential of 22.5%. On the other hand QuidelOrtho Corp. has an analysts' consensus of $37.67 which suggests that it could grow by 31.75%. Given that QuidelOrtho Corp. has higher upside potential than iRhythm Technologies, Inc., analysts believe QuidelOrtho Corp. is more attractive than iRhythm Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Technologies, Inc.11 2 0 QDELQuidelOrtho Corp.2 3 0 -
Is IRTC or QDEL More Risky?
iRhythm Technologies, Inc. has a beta of 1.099, which suggesting that the stock is 9.93% more volatile than S&P 500. In comparison QuidelOrtho Corp. has a beta of 0.584, suggesting its less volatile than the S&P 500 by 41.596%.
-
Which is a Better Dividend Stock IRTC or QDEL?
iRhythm Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. QuidelOrtho Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iRhythm Technologies, Inc. pays -- of its earnings as a dividend. QuidelOrtho Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or QDEL?
iRhythm Technologies, Inc. quarterly revenues are $192.9M, which are smaller than QuidelOrtho Corp. quarterly revenues of $700.5M. iRhythm Technologies, Inc.'s net income of -$5.2M is higher than QuidelOrtho Corp.'s net income of -$733M. Notably, iRhythm Technologies, Inc.'s price-to-earnings ratio is -- while QuidelOrtho Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Technologies, Inc. is 8.07x versus 0.71x for QuidelOrtho Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Technologies, Inc.8.07x -- $192.9M -$5.2M QDELQuidelOrtho Corp.0.71x -- $700.5M -$733M
-
Which has Higher Returns IRTC or TNDM?
Tandem Diabetes Care, Inc. has a net margin of -2.7% compared to iRhythm Technologies, Inc.'s net margin of -8.49%. iRhythm Technologies, Inc.'s return on equity of -54.18% beat Tandem Diabetes Care, Inc.'s return on equity of -110.24%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M TNDMTandem Diabetes Care, Inc.53.88% -$0.31 $582.2M -
What do Analysts Say About IRTC or TNDM?
iRhythm Technologies, Inc. has a consensus price target of $218.60, signalling upside risk potential of 22.5%. On the other hand Tandem Diabetes Care, Inc. has an analysts' consensus of $24.81 which suggests that it could grow by 9.68%. Given that iRhythm Technologies, Inc. has higher upside potential than Tandem Diabetes Care, Inc., analysts believe iRhythm Technologies, Inc. is more attractive than Tandem Diabetes Care, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Technologies, Inc.11 2 0 TNDMTandem Diabetes Care, Inc.7 13 0 -
Is IRTC or TNDM More Risky?
iRhythm Technologies, Inc. has a beta of 1.099, which suggesting that the stock is 9.93% more volatile than S&P 500. In comparison Tandem Diabetes Care, Inc. has a beta of 1.685, suggesting its more volatile than the S&P 500 by 68.536%.
-
Which is a Better Dividend Stock IRTC or TNDM?
iRhythm Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tandem Diabetes Care, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iRhythm Technologies, Inc. pays -- of its earnings as a dividend. Tandem Diabetes Care, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or TNDM?
iRhythm Technologies, Inc. quarterly revenues are $192.9M, which are smaller than Tandem Diabetes Care, Inc. quarterly revenues of $249.3M. iRhythm Technologies, Inc.'s net income of -$5.2M is higher than Tandem Diabetes Care, Inc.'s net income of -$21.2M. Notably, iRhythm Technologies, Inc.'s price-to-earnings ratio is -- while Tandem Diabetes Care, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Technologies, Inc. is 8.07x versus 1.50x for Tandem Diabetes Care, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Technologies, Inc.8.07x -- $192.9M -$5.2M TNDMTandem Diabetes Care, Inc.1.50x -- $249.3M -$21.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
